Related Experiment Videos
Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases
A Platz1, P Sevigny, T Norberg
1Department of Oncology, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Abstract:
A common characteristic of cancer cells is unrestrained cell division. This may be caused by mutational changes in genes coding for components of cell cycle-controlling networks. Alterations in genes involved in G1 checkpoint control have been registered in many human tumours, and investigations from several laboratories show that such alterations, taken together, are the most frequent changes detected in cancer cells. The present paper describes mutational analysis by polymerase chain reaction-single-strand conformation polymorphism (PCR/SSCP) and nucleotide sequence analysis of the genes coding for the p15, p53 and N-ras proteins in 26 metastases from 25 melanoma patients. The registered mutation frequencies add together with previously registered mutations in p16 in the same patient samples to a substantial total frequency of 44% of patients with mutation in at least one of the investigated genes. These results show the occurrence of heterogeneous defects among components of the cell cycle controlling machinery in a human melanoma tumour sample collection and demonstrate that the total frequency of detected alterations increases with the number of cell cycle controlling genes included in the screening panel.
Insights
Cancer cells exhibit unrestrained division due to mutations in cell cycle genes. This study found 44% of melanoma patients had mutations in key cell cycle genes, highlighting heterogeneous defects.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Unrestrained cell division is a hallmark of cancer, often driven by mutations in cell cycle regulatory genes.
- Alterations in G1 checkpoint control genes are frequently observed in human tumors, representing common molecular changes in cancer cells.
Purpose of the Study:
- To investigate mutations in cell cycle-controlling genes (p15, p53, N-ras) in melanoma patient samples.
- To determine the frequency of these mutations and assess their contribution to cell cycle dysregulation in melanoma.
Main Methods:
- Mutational analysis using polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP).
- Nucleotide sequence analysis of p15, p53, and N-ras genes.
- Analysis of 26 metastases from 25 melanoma patients.
Main Results:
- Identified mutations in p15, p53, and N-ras genes in melanoma samples.
- Combined with previously analyzed p16 mutations, a total of 44% of patients showed mutations in at least one investigated cell cycle gene.
- Demonstrated heterogeneous defects in cell cycle control machinery within the melanoma tumor collection.
Conclusions:
- Melanoma tumors exhibit diverse alterations in cell cycle regulatory genes.
- Screening a broader panel of cell cycle genes increases the detection rate of genetic alterations in cancer samples.
- These findings underscore the complex genetic landscape of melanoma and its impact on cell cycle control.